INmune Bio Ownership | Who Owns INmune Bio?

Overview Forecast RevenueFinancials Chart Transcripts

INmune Bio Ownership Summary

INmune Bio is owned by 30.56% institutional investors, 30.87% insiders, and 38.57% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 4.90% of INMB shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.04% of its assets in INmune Bio shares.

INMB Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	INmune Bio	30.56%	30.87%	38.57%
Sector	Healthcare Stocks	57.39%	9.93%	32.68%
Industry	Biotech Stocks	68.48%	9.65%	21.87%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Blackrock funding, inc. /de	989.56K	4.90%	$4.62M
Blackrock	812.89K	4.51%	$7.17M
Praetorian pr	812.21K	4.02%	$3.79M
Vanguard group	738.20K	3.66%	$3.45M
Cvi	596.37K	3.31%	$5.26M
Raymond james financial	475.55K	2.36%	$2.22M
Geode capital management	363.60K	1.80%	$1.70M
Millennium management	291.33K	1.44%	$1.36M
Raymond james financial services advisors	227.53K	1.26%	$2.01M
State street	226.43K	1.12%	$1.06M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Cvi	596.37K	4.54%	$5.26M
Praetorian pr	812.21K	1.52%	$3.79M
Diametric capital, lp	36.70K	0.12%	$171.38K
Westside investment management	89.97K	0.09%	$420.19K
Rhenman & partners asset management ab	178.28K	0.09%	$832.59K
Pekin hardy strauss	83.35K	0.05%	$389.24K
Fermata advisors	47.00K	0.04%	$219.48K
Xtx topco	61.27K	0.02%	$286.14K
Laird norton trust company	34.10K	0.02%	$159.25K
Financial advocates investment management	15.50K	0.00%	$72.39K

Top Buyers

Holder	Shares	% Assets	Change
Cvi	596.37K	4.54%	596.37K
Blackrock	812.89K	0.00%	572.73K
Raymond james financial	475.55K	0.00%	475.55K
Raymond james financial services advisors	227.53K	0.00%	227.53K
Ubs group	136.25K	0.00%	93.09K

Top Sellers

Holder	Shares	% Assets	Change
Corton capital	-	-	-76.14K
Heights capital management	-	-	-60.98K
Mai capital management	100.77K	0.00%	-59.99K
Royal bank of canada	20.63K	-	-41.46K
Squarepoint ops	-	-	-33.70K

New Positions

Holder	Shares	% Assets	Change	Value
Cvi	596.37K	4.54%	596.37K	$5.26M
Raymond james financial	475.55K	0.00%	475.55K	$2.22M
Raymond james financial services advisors	227.53K	0.00%	227.53K	$2.01M
Pekin hardy strauss	83.35K	0.05%	83.35K	$389.24K
Walleye capital	33.72K	0.00%	33.72K	$157.47K

Sold Out

Holder	Change
Fny investment advisers	-100.00
Nbc securities	-270.00
Macquarie group	-444.00
Valley national advisers	-1.00K
Redwood wealth management group	-2.20K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2024	74	8.82%	6,168,914	15.26%	30	4.35%	48	4.35%	7	-12.50%
Sep 30, 2024	65	8.33%	5,259,609	15.17%	26	4.06%	44	22.22%	8	-20.00%
Jun 30, 2024	60	11.11%	4,566,933	66.72%	25	10.88%	36	33.33%	10	-16.67%
Mar 31, 2024	54	3.85%	2,739,265	19.51%	15	9.42%	27	-3.57%	12	50.00%
Dec 31, 2023	52	26.83%	2,292,122	7.43%	12	9.00%	28	100.00%	8	-11.11%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	452.86K	2.04%	18.59K
Vanguard US Total Market Shares ETF	434.27K	1.91%	-
iShares Russell 2000 ETF	348.69K	1.52%	-3.02K
Vanguard Institutional Extnd Mkt Idx Tr	219.32K	0.99%	22.91K
Rhenman Healthcare Equity L/S RC2 SEK	178.28K	0.78%	-
Fidelity Small Cap Index	138.88K	0.61%	-2.60K
iShares Russell 2000 Growth ETF	116.81K	0.51%	-556.00
Fidelity Extended Market Index	83.72K	0.37%	-533.00
State St Russell Sm/Mid Cp® Indx NL Cl C	64.06K	0.29%	-
State St Russell Sm/Mid Cp® Indx SL Cl I	64.06K	0.28%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Sep 30, 2024	Moss David J	Chief Financial Officer	Buy	$52.87K
Sep 12, 2024	Tesi Raymond Joseph	President and CEO	Buy	$98.43K
Sep 12, 2024	Tesi Raymond Joseph	President and CEO	Buy	$98.05K
Sep 12, 2024	Moss David J	Chief Financial Officer	Buy	$49.22K
Sep 12, 2024	Moss David J	Chief Financial Officer	Buy	$49.02K

Insider Transactions Trends

Date	Buy	Sell
2024 Q3	5	-
2024 Q2	9	-
2023 Q4	1	-
2023 Q3	-	1
2023 Q1	1	-

INMB Ownership FAQ

Who Owns INmune Bio?

INmune Bio shareholders are primarily institutional investors at 30.56%, followed by 30.87% insiders and 38.57% retail investors. The average institutional ownership in INmune Bio's industry, Biotech Stocks , is 68.48%, which INmune Bio falls below.

Who owns the most shares of INmune Bio?

INmune Bio’s largest shareholders are Blackrock funding, inc. /de (989.56K shares, 4.90%), Blackrock (812.9K shares, 4.51%), and Praetorian pr (812.21K shares, 4.02%). Together, they hold 13.44% of INmune Bio’s total shares outstanding.

Does Blackrock own INmune Bio?

Yes, BlackRock owns 4.51% of INmune Bio, totaling 812.9K shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 7.17M$. In the last quarter, BlackRock increased its holdings by 572.73K shares, a 238.47% change.

Who is INmune Bio’s biggest shareholder by percentage of total assets invested?

Cvi is INmune Bio’s biggest shareholder by percentage of total assets invested, with 4.54% of its assets in 596.37K INmune Bio shares, valued at 5.26M$.

Who is the top mutual fund holder of INmune Bio shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of INmune Bio shares, with 2.04% of its total shares outstanding invested in 452.86K INmune Bio shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools